[{"ap_syndicated":null,"collect_date":"2019-11-15 07:49:45.022683","feeds":null,"guid":"http://www.globenewswire.com/news-release/2019/11/15/1947930/0/en/Emerald-Health-Therapeutics-Pure-Sunfarms-JV-Records-Q3-Net-Sales-of-24-0-Million-69-Gross-Margin-56-EBITDA-Margin-Fourth-Consecutive-Quarter-of-Positive-EBITDA-and-0-63-gram-All-i.html","language":"en","media_id":300377,"media_name":null,"media_url":null,"processed_stories_id":null,"publish_date":"2019-11-15 07:00:00","stories_id":1445878299,"story_tags":[{"stories_id":1445878299,"tag":"geonames_6093943","tag_set":"mc-geocoder@media.mit.edu","tag_sets_id":1011,"tags_id":8878531},{"stories_id":1445878299,"tag":"geonames_6251999","tag_set":"mc-geocoder@media.mit.edu","tag_sets_id":1011,"tags_id":8878548},{"stories_id":1445878299,"tag":"geonames_6173331","tag_set":"mc-geocoder@media.mit.edu","tag_sets_id":1011,"tags_id":8879072},{"stories_id":1445878299,"tag":"nyt_labeller_v1.0.0","tag_set":"nyt_labels_version","tag_sets_id":1964,"tags_id":9360669},{"stories_id":1445878299,"tag":"company reports","tag_set":"nyt_labels","tag_sets_id":1963,"tags_id":9361050},{"stories_id":1445878299,"tag":"corporations","tag_set":"nyt_labels","tag_sets_id":1963,"tags_id":9361051},{"stories_id":1445878299,"tag":"Delta","tag_set":"cliff_organizations","tag_sets_id":2388,"tags_id":9381122},{"stories_id":1445878299,"tag":"TSX","tag_set":"cliff_organizations","tag_sets_id":2388,"tags_id":9382901},{"stories_id":1445878299,"tag":"EBITDA","tag_set":"cliff_organizations","tag_sets_id":2388,"tags_id":9390266},{"stories_id":1445878299,"tag":"OCS","tag_set":"cliff_organizations","tag_sets_id":2388,"tags_id":9399468},{"stories_id":1445878299,"tag":"EMH","tag_set":"cliff_organizations","tag_sets_id":2388,"tags_id":9613099},{"stories_id":1445878299,"tag":"Emerald Health Therapeutics","tag_set":"cliff_organizations","tag_sets_id":2388,"tags_id":29959804},{"stories_id":1445878299,"tag":"Emerald Health Therapeutics, Inc.","tag_set":"cliff_organizations","tag_sets_id":2388,"tags_id":30915025},{"stories_id":1445878299,"tag":"YTD EBITDA","tag_set":"cliff_organizations","tag_sets_id":2388,"tags_id":32214333},{"stories_id":1445878299,"tag":"readability-lxml-0.7","tag_set":"extractor_version","tag_sets_id":1354,"tags_id":81092444},{"stories_id":1445878299,"tag":"Riaz Bandali","tag_set":"cliff_people","tag_sets_id":2389,"tags_id":181911989},{"stories_id":1445878299,"tag":"cliff_clavin_v2.6.0","tag_set":"geocoder_version","tag_sets_id":1937,"tags_id":189462640}],"title":"Emerald Health Therapeuticsâ€™ Pure Sunfarms JV Records Q3 Net Sales of $24.0 Million, 69% Gross Margin, 56% EBITDA Margin, Fourth Consecutive Quarter of Positive EBITDA, and $0.63/gram All-in Production Cost","url":"http://www.globenewswire.com/news-release/2019/11/15/1947930/0/en/Emerald-Health-Therapeutics-Pure-Sunfarms-JV-Records-Q3-Net-Sales-of-24-0-Million-69-Gross-Margin-56-EBITDA-Margin-Fourth-Consecutive-Quarter-of-Positive-EBITDA-and-0-63-gram-All-i.html","word_count":null}]